The consumer reported a conflicting result with the binaxnow covid-19 antigen self test otc 2 test pack on a nasal swab sample.The initial test performed generated a positive result.Repeat testing was performed the following day on a nasal swab and generated a negative result.The consumer reported that he was symptomatic ten days prior to testing.Technical services (ts) advised to obtain confirmation testing.No additional patient information, including treatment and outcome, was provided.
|
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 170055 with internal limit of detection (lod) positive quality control x3 devices and negative (blank) swabs x3 devices.All tests were valid and performed as expected with no conflicting results replicated.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160 lot 170055 and device part number 195-430h / lot 168079.Quality control release testing met specifications with no conflicting results observed.The current overall incident rate for false positive patient results (confirmed and unconfirmed, conflicting results) for this specific lot based on the total quantity of devices manufactured for distribution is(b)(4).Based on the evidence available, it indicates that this device lot is performing within label claims.No further action is required.Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue; however, it could possibly be related to issues including the self-test user performance, interpretation of the result, or the specific patient sample.
|